XOMA Acquires Royalty and Milestone Interest in Checkmate’s Vidutolimod (CMP-001) from Kuros Biosciences
July 15, 2021 04:00 ET
|
XOMA Corporation
EMERYVILLE, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), announced today it has acquired the royalty interest position Kuros Biosciences holds in Checkmate...
XOMA Declares Quarterly Preferred Stock Dividends
June 21, 2021 07:30 ET
|
XOMA Corporation
EMERYVILLE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to...
XOMA Licensees to Present Significant Clinical Data at 2021 ASCO Annual Meeting
May 21, 2021 08:00 ET
|
XOMA Corporation
EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) recently learned its licensees are presenting at the upcoming 2021 American Society of Clinical Oncology (ASCO)...
XOMA Reports First Quarter 2021 Financial Results and Highlights Recent Operational Events
May 06, 2021 07:30 ET
|
XOMA Corporation
XOMA’s portfolio of potential milestone and royalty assets now has greater than 70 drug candidates.Company ended the first quarter of 2021 with $67.8 million in cash. The April 2021 $40 million...
XOMA Earns Milestone for First Patient Dosed in Phase 3 Development Program
May 03, 2021 07:30 ET
|
XOMA Corporation
EMERYVILLE, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced it has earned a $0.5 million milestone from Janssen Biotech, Inc....
XOMA’s Royalty Portfolio Grows with Addition of Three Royalty Assets
April 15, 2021 09:05 ET
|
XOMA Corporation
EMERYVILLE, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) today announced its portfolio of potential future milestone and royalty assets has increased with the addition...
XOMA Announces Closing of Depositary Shares Offering and Exercise of Underwriters’ Option
April 12, 2021 07:30 ET
|
XOMA Corporation
Raised aggregate gross proceeds of $40 million Depositary shares represent an interest in 8.375% Series B Cumulative Perpetual Preferred Stock EMERYVILLE, Calif., April 12, 2021 (GLOBE NEWSWIRE)...
XOMA Prices $35 Million Offering of Depositary Shares
April 06, 2021 19:02 ET
|
XOMA Corporation
EMERYVILLE, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced the pricing of its underwritten registered public offering of...
XOMA Announces Offering of Depositary Shares and Series B Cumulative Perpetual Preferred Stock
April 05, 2021 16:05 ET
|
XOMA Corporation
EMERYVILLE, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced it has commenced an underwritten registered public offering of...
XOMA Announces Approval of First Preferred Stock Dividend
March 22, 2021 07:30 ET
|
XOMA Corporation
EMERYVILLE, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors approved a dividend of $0.71875 per share to...